Nav: Home

Researchers identify mutations causing butterfly-shaped eye pigment dystrophy

December 21, 2015

Bar Harbor, Maine - A butterfly-shaped pigment accumulation in the macula of the eye, which can lead to severe vision loss in some patients, is due to mutations in the alpha-catenin 1 gene (CTNNA1), an international research consortium including a team from The Jackson Laboratory reports in Nature Genetics.

The findings may have relevance to understanding macular degenerative diseases.

CTNNA1 encodes the protein CTNNA1, an alpha-catenin, which is part of the cellular machinery that glues cells to one another. Among CTNNA1's roles is building and maintaining the retinal pigment epithelium (RPE). This pigmented cell layer is critical for nourishing retinal visual cells and is sandwiched firmly between the neurosensory retina and the choroid, a capillary-rich tissue at the back of the eye.

The research team led by Anneke I. den Hollander, Ph.D., a professor at Radboud University Medical Center in Nijmegen, The Netherlands, identified CTNNA1 mutations in three families in which the butterfly-shaped pigment dystrophy of the eye is common. While relatively benign, this condition in some cases leads to severely impaired vision.

Independently, Professor Patsy Nishina's laboratory at The Jackson Laboratory discovered a mouse strain with an analogous mutation in the same gene as identified by den Hollander's team. Their collaboration revealed that the mouse model exhibits the same symptoms as the human patients, including pigmentary abnormalities, focal thickening, elevated lesions, and decreased light-activated responses in the RPE.

The researchers theorize that, although CTNNA1 is expressed in both the retina and the RPE, the disease is caused by defects in the RPE. CTNNA1 is a central component of intercellular adherens junctions, which are critical for maintaining RPE integrity.

The finding that the CTNNA1 mutations are a cause of butterfly-shaped pigment dystrophy supports the hypothesis that defects in the cadherin-based intercellular adhesion system may contribute to macular degenerative diseases.

Nishina comments, "This research nicely demonstrates the 'virtuous loop' between findings in patient data and how a good mouse model equivalent can provide detailed insight into the mechanisms of a disease."

Other Jackson Laboratory researchers collaborating in the research were Mark P. Krebs, Wanda Hicks, Lanying Shi, Lucy Rowe, Gayle B. Collin and Jeremy R. Charette.

The Jackson Laboratory is an independent, nonprofit biomedical research institution and National Cancer Institute-designated Cancer Center. It employs 1,700 staff, and its mission is to discover precise genomic solutions for disease and empower the global biomedical community in the shared quest to improve human health.
-end-


Jackson Laboratory

Related Disease Articles:

Viewpoint: Could disease pathogens be the dark matter behind Alzheimer's disease?
In a lively discussion appearing in the Viewpoint section of the journal Nature Reviews Neurology, Ben Readhead, a researcher in the ASU-Banner Neurodegenerative Disease Research Center at the Biodesign Institute joins several distinguished colleagues to discuss the idea that bacteria, viruses or other infectious pathogens may play a role in Alzheimer's disease.
Tools used to study human disease reveal coral disease risk factors
In a study published in Scientific Reports, a team of international researchers led by University of Hawai'i (UH) at Mānoa postdoctoral fellow Jamie Caldwell used a statistical technique typically employed in human epidemiology to determine the ecological risk factors affecting the prevalence of two coral diseases--growth anomalies, abnormalities like coral tumors, and white syndromes, infectious diseases similar to flesh eating bacteria.
Disease-aggravating mutation found in a mouse model of neonatal mitochondrial disease
The new mitochondrial DNA (mtDNA) variant drastically speeds up the disease progression in a mouse model of GRACILE syndrome.
Human longevity largest study of its kind shows early detection of disease & disease risks
Human Longevity, Inc. (HLI) announced the publication of a ground-breaking study in the journal Proceedings of the National Academy of Sciences (PNAS).
30-year study identifies need of disease-modifying therapies for maple syrup urine disease
A new study analyzes 30 years of patient data and details the clinical course of 184 individuals with genetically diverse forms of Maple Syrup Urine Disease (MSUD), which is among the most volatile and dangerous inherited metabolic disorders.
Long-dormant disease becomes most dominant foliar disease in New York onion crops
Until recently, Stemphylium leaf blight has been considered a minor foliar disease as it has not done much damage in New York since the early 1990s.
Inflammatory bowel disease appears to impact risk of Parkinson's disease
Amsterdam, NL, November 14, 2019 - Relatively new research findings indicating that the earliest stages of Parkinson's disease (PD) may occur in the gut have been gaining traction in recent years.
Contact sports associated with Lewy body disease, Parkinson's disease symptoms, dementia
There is mounting evidence that repetitive head impacts from contact sports and other exposures are associated with the neurodegenerative disease chronic traumatic encephalopathy (CTE) and dementia.
In kidney disease patients, illicit drug use linked with disease progression and death
Among individuals with chronic kidney disease, hard illicit drug use was associated with higher risks of kidney disease progression and early death.
Despite reductions in infectious disease mortality in US, diarrheal disease deaths on the rise
Deaths from infectious diseases have declined overall in the United States over the past three decades.
More Disease News and Disease Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Clint Smith
The killing of George Floyd by a police officer has sparked massive protests nationwide. This hour, writer and scholar Clint Smith reflects on this moment, through conversation, letters, and poetry.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at Radiolab.org/donate.